Across TCGA patient cohorts, CDHR4 mutation is significantly associated with the RNA expression of many other genes, with 1,552 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CDHR4-associated genes across cancer lineages are RPS29P32, MIR4311, and RNVU1-28. Each is linked with CDHR4 in more than 2 cancer types. Because this analysis shows association rather than direction, both CDHR4-to-partner and partner-to-CDHR4 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CDHR4→partner) and Y-score (partner→CDHR4) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BRCA	RPS29P32 →	+0.342	+5.234	<.001	.002	3	3
CESC	MIR4311 →	+0.255	+5.144	.008	.003	3	2
CESC	RNVU1-28 →	+0.755	+4.705	<.001	.003	3	2
CESC	MTND2P23 →	+0.058	+4.539	.007	.008	3	2
SKCM	DNAJB6P8 →	+0.124	+3.333	<.001	.004	3	2
UCEC	MIR6803 →	+0.105	+3.893	<.001	.006	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 1,552 associations by consensus.

Exploration

CDHR4 survival (RNA) · tumor vs normal (RNA) · all CDHR4 data types